Best Healthcare Companies in Wilmington, United States
The 90 best Healthcare companies in Wilmington, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: PPD.
Ranked: Best Healthcare companies in Wilmington
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | PPD CRO providing diversified clinical development services 87Funding top 18%Fin. health top 19%Market top 23%Moat top 34% All 8 signals ▾Fundingtop 18% Fin. healthtop 19% Markettop 23% Moattop 34% Techtop 38% Growthbottom 48% Globalbottom 46% Newsbottom 35% Funding: Raised $1.0B across 5 rounds · 5 rounds over 3 yrs (1.7/yr) Fin. health: Revenue ~$4.7B (FY2021) · Net margin 10.7% rank vs industry peers · Fliar Intelligence Index 87/100 | $1.0B | 32 mo ago | Acquired | — | 1985 | WordPress Block EditorWordPressMySQL+27 | — | — |
| 2 | Westside Family Healthcare Provider of integrated medical and dental healthcare services 67Funding top 29%Growth top 35%Market top 45%Tech bottom 47% All 5 signals ▾Fundingtop 29% Growthtop 35% Markettop 45% Techbottom 47% Globalbottom 33% Funding: Raised $310M across 22 rounds · 22 rounds over 19 yrs (1.2/yr) Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 67/100 | $310M | 12 mo ago | Funding Raised | — | 1988 | WordPressMySQLPHP+20 | — | — |
| 3 | Orbi Health Provider of healthcare management services | $11M | 48 mo ago | Series A | Vikalp Sahni Co-Founder | 2020 | — | — | — |
| 4 | Inclinix Customized clinical trial enrollment solution | $10M | 188 mo ago | Acquired | — | 1999 | — | — | — |
| 5 | Prevod R&D company focused on manufacturing drugs for multiple therapeutic areas | $9M | 50 mo ago | Series A | Lawrence Hamann CEO | 2022 | — | — | — |
| 6 | Meroka Facilitator of employee-owned medical practice transitions | $6M | 9 mo ago | Seed | Alex Meroka Co-Founder & CEO | 2023 | WebflowApple iCloud MailGSAP+13 | — | — |
| 7 | CuriRx Pharmaceutical CRDMO providing innovative drug development solutions and analytical services | $2M | 47 mo ago | Seed | Indu Javeri President & CEO | 2011 | — | 17 patents Enteric drug delivery formulations and liposome-based pharmaceutical preparation | 1 job opening |
| 8 | Beckley Retreats Foundation focused on psychedelic & influencing policy research | $2M | 3 mo ago | Series A | Neil Markey Co-Founder & CEO | 2021 | WebflowWordPressMySQL+38 | — | — |
| 9 | Chrysalis Provider of mental health and eating disorder treatment services | $303K | 195 mo ago | Funding Raised | — | 2003 | WordPressMySQLPHP+17 | 4 patents Epigenetic drug discovery (histone demethylase inhibition) and mobile broadband modem technology. | — |
| 10 | Simon Eye Associates Chain of eye care clinics | — | 1 mo ago | Late Stage | — | 1987 | WordPressMySQLPHP+31 | — | — |
| 11 | Weill Cornell Provider of comprehensive medical services and digital health solutions. | — | 12 mo ago | Funding Raised | — | — | DrupalMariaDBPHP+23 | — | 2 awards |
| 12 | Charles River Laboratories Provider of drug discovery and preclinical development services | — | 24 mo ago | Public | James Foster Chairman | 1947 | WordPressApple iCloud MailMySQL+41 | 92 patents Recombinant clotting reagents, gene‑engineered adoptive cell therapy tools, and automated cell counting technologies. | — |
Top 12 Healthcare companies in Wilmington
#1
Funding Raised · Wilmington, Delaware · founded 1988 · 213 employees$310.1Mraised▾
Provider of integrated medical and dental healthcare services. This entity offers primary care, women's health, pediatric health, behavioral healthcare, and support programs. Services include prenatal care and telehealth options. They also provide access to medical records and offer financial assistance. The organization operates health centers and maintains a provider-on-call service for urgent needs. Additional offerings encompass educational training and various community outreach initiatives.
- 2025Grant (prize money)$3.6M
- Mar 2025Grant (prize money)$6.1M
- Jan 2025Grant (prize money)$5M
- 2024Grant (prize money)$13.4M
#2
Series A · Wilmington, Delaware · founded 2021 · 18 employees$1.5Mraised▾
Provider of a week-long virtual integration program intended to offer scientific insights and psychedelic retreats. The company focuses on helping those with neurological and psychiatric disorders and offers training and certification for practitioners, enabling customers to access safe, legal, and transformative psychedelic ceremonies.
- Feb 2026Series A$6.1M
- Oct 2022Seed$1.5M
#3
Acquired · Wilmington, North Carolina · founded 1985 · 1530 employees$1Braised▾
CRO providing diversified clinical development services
- Oct 2023Grant (prize money)$126.5M
- May 2019Conventional Debt$900M
- Dec 2011PE—
- Aug 2009Grant (prize money)$7.1M
#4
Seed · Wilmington, Delaware · founded 2023$6Mraised▾
Facilitator of employee-owned medical practice transitions. This company assists independent physicians in transferring ownership of their practices to their employees. The process aims to keep local businesses within the community and preserve the independence of medical practices. The company provides support and guidance throughout the transition, helping physicians maintain control while ensuring the continued success of their practices. Resources and support are offered to navigate the complexities of this ownership transfer, enabling physicians to focus on patient care.
- Sep 2025Seed$6M
#5
Series A · Wilmington, Delaware · founded 2020$10.7Mraised▾
Provider of healthcare management services
#6
Series A · Wilmington, Delaware · founded 2022$9Mraised▾
R&D company focused on manufacturing drugs for multiple therapeutic areas
#7
Seed · Wilmington, Massachusetts · founded 2011 · 29 employees$2.5Mraised▾
Pharmaceutical CRDMO providing innovative drug development solutions and analytical services. They offer a broad range of services to pharmaceutical companies, including formulation development, prefilled syringes, lyophilization, nanotechnology, and advanced bioprocessing. Their expertise extends to cell line and strain development, upstream and downstream process development, and comprehensive analytical services through their CuriLytics platform. They provide CMC analytical support, high-resolution mass spectrometry, and analytical testing services for biopharmaceuticals, biologics, small molecule pharmaceuticals, and gene therapy. Quality testing, qualification, validation, and stability studies are also key offerings. They envision new standards of therapeutic care by providing innovative drug development solutions, aiming to improve the lives of patients through high-quality services and products. They foster a collaborative work environment built on respect, teamwork, excellence, creativity, gratitude, and a commitment to continuous improvement.
- Jul 2022Seed$2.5M
#8
Acquired · Wilmington, North Carolina · founded 1999 · 75 employees$10.5Mraised▾
Customized clinical trial enrollment solution
- Sep 2010Series B$500K
- Jan 2008Series B$10M
#9
Funding Raised · Wilmington, North Carolina · founded 2003$303Kraised▾
Provider of mental health and eating disorder treatment services. These services include individual and group therapy for adults, teens, and children, family and couples counseling, nutritional counseling, medication management, and intensive outpatient programs for eating disorders and trauma. Evaluations for bariatric surgery patients are also offered, along with virtual telehealth services. The treatment approach emphasizes empathetic, non-judgmental care and meaningful therapeutic relationships. Licensed clinicians provide these services
- Mar 2010Grant (prize money)$42.3K
- Jan 2010Grant (prize money)$56.1K
- Apr 2008Grant (prize money)$106.2K
- Jul 2007Grant (prize money)$42.3K
#10
Late Stage · Wilmington, Delaware · founded 1987 · 140 employees—raised▾
Chain of eye care clinics
- May 2026PE—
#11
Funding Raised · Wilmington, North Carolina · 8 employees—raised▾
{}
#12
Public · Wilmington, Massachusetts · founded 1947 · 21400 employees—raised▾
Charles River Labs offers drug discovery and preclinical development services to pharma and biotech companies. Their services span the entire drug discovery pathway namely target discovery and validation, hit finding, medicinal chemistry, in vivo and in-vitro pharmacology, biomarker development, and IND-enabling studies for both small molecules and biologics. They cater to therapeutic areas such as Oncology, CNS/pain, Inflammation, Immunology, Cardiovascular, Metabolic, Respiratory, Rare and neglected diseases, and others. In 2020, the company recorded annual revenues of $2.9 B and a net profit of $364.3 M.
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Healthcare coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.